Gómez-Gómez B, Sánchez-Luna JP, Pérez-Beltrán CF, Díaz-Greene EJ, Rodríguez-Weber FL

Language: Spanish
References: 28
Page: 381-391
PDF size: 387.66 Kb.

ABSTRACT

Globally, the prevalence of sepsis is more than 19 million cases per year with an estimated mortality of 30%. The most frequently identified risk factors are chronic diseases (HIV-AIDS, COPD and neoplasms) and the use of immunosuppressive agents. The most susceptible population to develop these complications are the ones in babyhood or the elderly. Among the multiple pathogens, bacteria are considered the microorganisms primarily involved in the development of severe sepsis. Within the foci of infection, pneumonia is considered to be the most common, followed by intra-abdominal infections, urinary tract and primary bloodstream infections. It has been demonstrated that early treatment significantly improves survival. Interventions to be performed include antimicrobial therapy, fluid resuscitation, ventilatory support and supportive measures (antithrombotic prophylaxis, glycemic control and prophylaxis to prevent stress gastric ulcers and nutrition).

REFERENCES

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420(6917):885-891.

2. Angus DC, van der Poll T. Severe sepsis and septic shock. New Engl J Med 2013;369(21):2063.

3. Dellinger RP, Bone RC. To SIRS with love. Crit Care Med 1998;26(1):178-179.

4. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39(2):165-228.

5. Rivers EP. Early goal-directed therapy in severe sepsis and septic shock: converting science to reality. Chest 2006;129(2):217-218.

6. Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749-1755.

7. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32(3):858-873.

8. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36(1):296-327.

9. Cecconi M, Hofer C, Teboul JL, Pettila V, Wilkman E, Molnar Z, et al. Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med 2015;41(9):1529-1537.

10. Pro CI, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. New Engl J Med 2014;370(18):1683- 1693.

11. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008;134(1):172-178.

12. Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy. Ann Intensive Care 2011;1(1):1.

13. Monnet X, Teboul JL. Passive leg raising: keep it easy! Intensive Care Med 2010;36(8):1445;author reply 446.

14. Fuller BM, Dellinger RP. Hemodynamic resuscitation in septic shock: cardiovascular support and adjunctive therapy. Curr Infect Dis Rep 2009;11(5):357-364.

15. Investigators A, Group ACT, Peake SL, Delaney A, et al. Goaldirected resuscitation for patients with early septic shock. New Engl J Med 2014;371(16):1496-1506.

16. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock. Health Technol Assess 2015;19(97):1-150.

17. Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. New Engl J Med 2014;370(17):1583- 1593.

18. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014;40(12):1795-1815.

19. Monnet X, Teboul JL. Minimally invasive monitoring. Crit Care Clin 2015;31(1):25-42.

20. Monnet X, Teboul JL. Passive leg raising: five rules, not a drop of fluid! Crit care 2015;19:18.

21. Levy MM, Rhodes A, Phillips GS, Townsend SR, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med 2014;40(11):1623-1633.

22. Schorr CA, Dellinger RP. The Surviving Sepsis Campaign: past, present and future. Trends Mol Med 2014;20(4):192- 194.

23. Casserly B, Phillips GS, Schorr C, Dellinger RP, Townsend SR, Osborn TM, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med 2015;43(3):567-573.

24. Boulain T, Garot D, Vignon P, Lascarrou JB, Desachy A, Botoc V, et al. Prevalence of low central venous oxygen saturation in the first hours of intensive care unit admission and associated mortality in septic shock patients: a prospective multicentre study. Crit Care 2014;18(6):609.

25. Osborn TM, Phillips G, Lemeshow S, Townsend S, Schorr CA, Levy MM, et al. Sepsis severity score: an internationally derived scoring system from the surviving sepsis campaign database*. Crit Care Med 2014;42(9):1969-1976.

26. Dellinger RP. Foreword. The Future of Sepsis Performance Improvement. Crit Care Med 2015;43(9):1787-1789.

27. Marik PE. The demise of early goal-directed therapy for severe sepsis and septic shock. Acta Anaesthesiologica Scandinavica 2015;59(5):561-567.

28. Gutierrez Junco SM, Paipa Merchan AJ, Heredia Rodriguez M, Gomez Herreras JI, Tamayo Gomez E. The Resuscitation Bundle of the Surviving Sepsis Campaign Beyond Early Goal-Directed Therapy: What’s Next? Crit Care Med 2015;43(8):e319-e320.